Tonix Pharmaceuticals Holding Corp (TNXP)
Stock-Based Compensation
$2.26M
Quarterly · Period ending: · USD
TNXP Stock-Based Compensation
Latest reported$2.26Mperiod ending
Latest reported$2.26Mperiod ending
TNXP Quarterly Stock-Based Comp ($0.00 → $2.26M)
Quarterly stock-based compensation
High-resolution chart · PNG
TNXP stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,256,000 | |
| 1,970,000 | |
| 1,807,000 | |
| 0 | |
| 1,423,000 | |
| 882,000 | |
| 894,000 | |
| 1,038,000 | |
| 1,154,000 | |
| 1,692,000 | |
| 2,038,000 | |
| 2,079,000 | |
| 2,364,000 | |
| 2,794,000 | |
| 0 | |
| 2,765,000 | |
| 2,813,000 | |
| 2,620,000 | |
| 2,296,000 | |
| 2,302,000 | |
| 2,089,000 | |
| 1,212,000 | |
| 871,000 | |
| 912,000 | |
| 733,000 | |
| 360,000 | |
| 359,000 | |
| 362,000 | |
| 431,000 | |
| 305,000 | |
| 368,000 | |
| 451,000 | |
| 409,000 | |
| 399,000 | |
| 313,000 | |
| 433,000 | |
| 477,000 | |
| 567,000 | |
| 899,000 | |
| 744,000 | |
| 727,000 | |
| 896,000 | |
| 1,005,000 | |
| 862,000 | |
| 1,174,000 | |
| 1,348,000 | |
| 1,000,000 | |
| 884,000 | |
| 651,000 | |
| 553,000 | |
| 441,534 | |
| 441,571 | |
| 441,572 | |
| 392,323 | |
| 293,828 | |
| 342,798 | |
| 228,532 | |
| 0 | |
| 0 | |
| 45,172 | |
| 53,656 | |
| 40,236 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |